Global Infectious Disease Diagnostics Market Report 2022-2032: Shift in Focus from Centralized Laboratories to Decentralized POC Testing Bolsters Growth
29. Juni 2023 04:03 ET
|
Research and Markets
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostics Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.Growing Prevalence of Infectious...
Global Infection Surveillance Solutions Market 2023 - 2030: Increasing Adoption of Inorganic Growth Strategies Fuels the Sector
19. April 2023 10:33 ET
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User (Hospitals, Clinics, Ambulatory Surgical Center,...
Global Infection Surveillance Solutions Markets, 2020-2021 & 2022-2026: Growing Number of HAIs, Continuing Advancements and Innovations and More Expenditure on Healthcare Driving Growth
05. April 2022 07:38 ET
|
Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
U.S. Infection Prevention and Control (IPC) in Outpatient Care Facilities: COVID-19 Pandemic, Healthcare Staff Shortage and Digital Tools Boost IPC Solution Adoption
25. Februar 2022 06:38 ET
|
Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "United States Infection Prevention and Control (IPC) in Outpatient Care Facilities Growth Opportunities" report has been added to...
Global Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products Market Report to 2026 - Featuring Gilead Sciences, Merck and Novartis Among Others
01. Juli 2021 04:53 ET
|
Research and Markets
Dublin, July 01, 2021 (GLOBE NEWSWIRE) -- The "Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026" report has been added to ResearchAndMarkets.com's...
EPA Approves New, Broader Pathogen Killing Claims for Applied Silver’s SilvaClean® Commercial Laundry Additive Now Used in Healthcare and Sports Medicine Programs
28. März 2019 13:19 ET
|
Applied Silver Inc.
EPA Agrees SilvaClean® Kills MRSA and a Broad Range of Antibiotic-Resistant Pathogens Company Appoints Mark Neaman, former Chairman, President and CEO of NorthShore (IL) University Health Systemto...